ProfileGDS5678 / 1453254_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 42% 36% 36% 35% 36% 37% 36% 36% 36% 36% 36% 36% 39% 36% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0169342
GSM967853U87-EV human glioblastoma xenograft - Control 22.8294436
GSM967854U87-EV human glioblastoma xenograft - Control 32.8321936
GSM967855U87-EV human glioblastoma xenograft - Control 42.7543335
GSM967856U87-EV human glioblastoma xenograft - Control 52.773336
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.9165737
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.8720136
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.8069836
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.7909736
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.8066136
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.8146336
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.7783236
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9027339
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.8179536